Vincent S. Lopriore
Executive Chairman, Director · Hepion Pharmaceuticals, Inc.
- 2025
- Sep 14, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vincent S. Lopriore files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael J. Purcell - $150K in HEPA purchases and sales in the last 12 months
- Sireesh Appajosyula - $150K in HEPA purchases and sales in the last 12 months
- Gary S. Stetz - $150K in HEPA purchases and sales in the last 12 months
- Gary S. Stetz II - $25K in HEPA purchases and sales in the last 12 months
- Danina Fisher - $10K in HEPA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vincent S. Lopriore?
Vincent S. Lopriore is a corporate insider, tracked as Executive Chairman, Director of Hepion Pharmaceuticals, Inc. (HEPA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Vincent S. Lopriore submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Vincent S. Lopriore been buying or selling stock?
Recorded transactions: 7 open-market purchases ($750K) and 0 open-market sales across all tracked filings.
